The January–March period 2014 in brief
· Net sales amounted to MSEK 6.4 (8.1), first quarter last year included amortized upfront fees of MSEK 2,5
· Net loss for the group was MSEK 13.4 (10.7)
· Loss per share was SEK 0.03 (0.02)
· Cash flow from operating activities was MSEK -13.1 (-9.9)
· Cash and cash equivalents and other short-term investments totaled MSEK 8.6 (48.0) at the end of the period
· Financing of MSEK 1 granted by Vinnova for ERbeta cancer project
Help employers find you! Check out all the jobs and post your resume.
